drugset / Trial / NCT02640443

Sulfamethoxazole for the Treatment of Primary PREPL Deficiency

NCT02640443

NaSingle-groupSingle-blindTreatment

Summary

The investigators will evaluate whether sulfamethoxazole, a sulfamide antibiotic, improves the symptoms of primary PREPL deficiency (hypotonia-cystinuria syndrome and isolated PREPL deficiency).

Timeline

Start
2015-10
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Sulfamethoxazole Small molecule 60 mg/kg